NHUNG TRAN: Open Payments
NPI 1386675775 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,797 in 153 payments from 21 companies in 2025. Trend: 2023 $1,848 · 2024 $2,267 · 2025 $2,797
Food & beverage: $2,787Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $613 |
| ABBVIE INC. | 28 | $530 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $425 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $262 |
| Phathom Pharmaceuticals, Inc. | 14 | $155 |
| Madrigal Pharmaceuticals | 3 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
| Ardelyx, Inc. | 4 | $86 |
| Novo Nordisk Inc | 3 | $86 |
| Lilly USA, LLC | 5 | $81 |
Products named: TREMFYA, ENTYVIO, XIFAXAN, LINZESS, RINVOQ, VOQUEZNA, DUPIXENT, EOHILIA.
Industry payments across NY — which companies pay providers there.
